Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: Prospective experience of a dental oncology referral center

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 112, Issue 2, 2011, Pages 195-202

  Nicolatou Galitis, Ourania ^a   Papadopoulou, Erofili ^a   Sarri, Triantafyllia ^a   Boziari, Polyxeni ^a   Karayianni, Aikaterini ^a   Kyrtsonis, Marie Christine ^b   Repousis, Panagiotis ^c   Barbounis, Vassilios ^d   Migliorati, Cesar A ^e  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c METAXA CANCER HOSPITAL   (Greece)

^d KAT HOSPITAL   (Greece)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICARIES AGENT; ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CHLORHEXIDINE; FLUORIDE; IMIDAZOLE DERIVATIVE; PAMIDRONIC ACID; TOPICAL ANTIINFECTIVE AGENT; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAW DISEASE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MOUTH HYGIENE; NEOPLASM; PAIN ASSESSMENT; PREVENTIVE DENTISTRY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BONE DENSITY CONSERVATION AGENTS; CARIOSTATIC AGENTS; CHLORHEXIDINE; DENTAL PROPHYLAXIS; DIPHOSPHONATES; FEMALE; FLUORIDES; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; INJECTIONS, INTRAVENOUS; JAW DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; ORAL HYGIENE; OSTEONECROSIS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960233317     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2011.02.037     Document Type: Article

References (34)

1. C.A. Migliorati, M.M. Schubert, and D.E. Peterson Bisphosphonate osteonecrosis (BON): unanswered questions and research possibilities Rev Recent Clin Trials 4 2009 99 109
2. S. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws2009 update J Oral Maxillofac Surg 67 Suppl 2009 2 12
3. C.A. Migliorati, S.B. Woo, I. Hewson, A. Barasch, L. Elting, and F. Spijkervet A systematic review of bisphosphonate osteonecrosis (BON) in cancer Support Care Cancer 18 2010 1099 1106
4. J. Wang, N.M. Goodger, and M.A. Pogrel Osteonecrosis of the jaws associated with cancer chemotherapy J Oral Maxillofac Surg 61 2003 1104 1107 (Pubitemid 37064708)
5. S. Ruggiero, B. Mebrotra, T. Rosenberg, and S. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534 (Pubitemid 38542516)
6. J.V. Bagan, J. Murillo, Y. Jimenez, R. Poveda, M.A. Milian, and J.M. Sanchis Avascular jaw osteonecrosis in association with cancer chemotherapy: a series of 10 cases J Oral Pathol Med 34 2005 120 123
7. C.A. Migliorati, M.M. Schubert, D.E. Peterson, and L.M. Seneda Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone An emerging oral complication of supportive care therapy Cancer 104 2005 83 93 (Pubitemid 40847755)
8. C.A. Migliorati, B.N. Armonis, and O. Nicolatou-Galitis Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 2008 e18 e21
9. A. Bamias, E. Kastritis, C. Bamia, L. Moulopoulos, I. Melakopoulos, and G. Bozas Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 2005 8580 8587 (Pubitemid 46211499)
10. B.G.M. Durie, M. Katz, and J. Crowley Osteonecrosis of the jaw and bisphosphonates N Engl J Med 353 2005 99 102
11. T. Mavrokokki, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423 (Pubitemid 46343586)
12. C. Walter, B. Al-Nawas, K.A. Grotz, C. Thomas, J.W. Thuroff, and V. Zinser Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate Eur Urol 54 2008 1066 1072
13. T. Boonyapakorn, I. Schirmer, P.A. Reichart, I. Sturm, and G. Massenkeil Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies Oral Oncol 44 2008 857 869
14. A. Kyrgidis, K. Vahtsevanos, G. Koloutsos, C. Andreadis, I. Boukovinas, and Z. Teleiouidis Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients J Clin Oncol 26 2008 4634 4638
15. K. Vahtsevanos, A. Kyrgidis, E. Verrou, E. Katodritou, S. Triaridis, and C. Andreadis Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw J Clin Oncol 27 2009 5356 5362
16. T. Van den Wyngaert, T. Claeys, M.T. Huizing, J.B. Vermorken, and E. Fossion Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome Ann Oncol 20 2009 331 336
17. C. Walter, B. Al-Navas, N. Frickhofen, H. Gamm, J. Beck, and L. Reinsch Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients Head Face Med 6 2010 11
18. E.P. Wang, L.B. Kaban, G.L. Strewler, N. Raje, and M.J. Troulis Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy J Oral Maxillofac Surg 65 2007 1328 1331 (Pubitemid 46915477)
19. F. Jadu, L. Lee, M. Pharaoh, D. Reece, and L. Wang A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients Ann Oncol 18 2007 2015 2019 (Pubitemid 350286242)
20. A.O. Hoff, B.B. Toth, K. Altundag, M.M. Johnson, C.L. Warneke, and M. Hu Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826 836 (Pubitemid 351768801)
21. C. Walter, B. Al-Nawas, A. du Bois, L. Buch, P. Harter, and K.A. Grotz Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients Cancer 115 2009 1631 1637
22. K. Zervas, E. Verrou, Z. Teleioudis, K. Vahtsevanos, A. Banti, and D. Mihou Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients Br J Hematol 134 2006 620 623 (Pubitemid 44253605)
23. J.H. Wessel, T.B. Dodson, and A.I. Zavras Zoledronate and other risk factors associated with osteonecrosis of the jaw in cancer patients: a case-control study J Oral Maxillofac Surg 66 2008 625 631 (Pubitemid 351381804)
24. C.L. Estilo, C.H. Van Poznak, T. Williams, G.C. Bohle, P.T. Lwin, and Q. Zhou Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy Oncologist 13 2008 911 920
25. N. La Verde, C. Bareggi, M. Garassino, K. Borgonovo, P. Sburlati, and D. Pedretti Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution Support Care Cancer 16 2008 1311 1315
26. S.-B. Woo, J.W. Hellstein, and J.R. Kalmar Systematic review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761 (Pubitemid 46780635)
27. S.L. Ruggiero, J. Gralow, R.E. Marx, A.O. Hoff, M.M. Schubert, and J.M. Huryn Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer J Oncol Pract 2 2006 7 14
28. S.L. Ruggiero, J. Fantasia, and E. Carlson Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 433 441 (Pubitemid 44403162)
29. M. Dickinson, H.M. Prince, S. Kirsa, A. Zannettino, S.D.J. Gibbs, and L. Mileshkin Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment Intern Med J 39 2009 304 316
30. C. Migliorati, J. Casiglia, J. Epstein, P. Jacobsen, M. Siegel, and S. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper J Am Dent Assoc 136 2005 1658 1668 (Pubitemid 41810027)
31. M.A. Dimopoulos, E. Kasritis, C. Bamia, I. Melakopoulos, D. Gika, and M. Roussou Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zolendronic acid Ann Oncol 20 2009 117 120
32. C.I. Ripamonti, M. Maniezzo, T. Campa, E. Fagnoni, C. Brunelli, and G. Saibene Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumor patients with bone metastases treated with bisphosphonates The experience of the National Cancer Institute of Milan Ann Oncol 20 2009 137 145
33. A. Badros, E. Terpos, E. Katodritou, O. Goloubeva, E. Kastritis, and E. Verrou Natural history of osteonecrosis of the jaw in patients with multiple myeloma J Clin Oncol 26 2008 5904 5909
34. C. Magopoulos, G. Karakinaris, Z. Teleioudis, K. Vahtsevanos, I. Dimitrakopoulos, and K. Antoniadis Osteonecrosis of the jaws due to bisphosphonate use A review of 60 cases and treatment proposals Am J Otolaryngol 28 2007 158 163 (Pubitemid 46702356)